UFP Technologies Q3 EPS flat at $2.11; sales up 6.5% but organic sales flat due to labor issue

UFP TECHNOLOGIES INC

2025-Q3 EPS reported $6.52 revenue$453,882,000

Q3 net income $16.4M ($2.11 diluted EPS), flat YoY; adjusted EPS $2.39.
Sales $154.6M (+6.5% YoY); MedTech up 7.3% to $142.4M; non-medical down 2.7%.
Gross margin fell to 27.7% from 28.6% due to ~$3M incremental labor cost at Illinois AJR facility; absent that, would have been 29.6%.
Organic sales flat; over $8M in orders unfulfilled due to labor eligibility review at AJR; Q4 impact expected to be significantly less.
Two new robotic surgery programs on track for commercial production by year-end; CEO expects significant 2026+ revenue.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.